Company Search:
Advanced Search
Sponsored Links
Haemato AG Company Snapshot
Haemato AG operates in the Drugs, proprietaries, and sundries sector. In addition to historical fundamental analyses, the complete report available to purchase compares Haemato AG with three other drug stores in Europe: Salus Ljubljana DD of Slovenia (2016 sales of 220.06 million Euro [US$273.03 million] ), Medika d.d. of Croatia (2.66 billion Croatian Kuna [US$444.36 million] ), and Sopharma Trading AD which is based in Bulgaria (619.28 million Bulgarian Lev [US$392.95 million] ).

Sales Analysis. Haemato AG reported sales of 275.61 million Euro (US$341.95 million) for the year ending December of 2016. This represents an increase of 20.0% versus 2015, when the company's sales were 229.73 million Euro. Sales at Haemato AG have increased during each of the previous five years (and since 2011, sales have increased a total of 1,877%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Haemato AG
  Stock Performance Chart for Haemato AG
  Stock Data: Recent Stock Performance:
  Current Price (2/16/2018): 5.82
(Figures in Euro)
1 Week 2.1%   13 Weeks 4.3%  
4 Weeks 8.6%   52 Weeks -12.3%  
Haemato AG Key Data:
  Ticker: HAE Country: Germany
  Exchanges: FRA Major Industry: Health Care Equipment & Services
    Sub Industry: Drugs, Proprietaries, & Sundries
  2016 Sales 275,613,691
(Year Ending Jan 2017).
Employees: 181
  Currency: Euro Market Cap: 127,923,600
  Fiscal Yr Ends: December Shares Outstanding: 21,980,000
  Share Type: Inhaberstammaktien Closely Held Shares:
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.